Barrier Capacity of Human Placenta for Nanosized Materials

Background Humans have been exposed to fine and ultrafine particles throughout their history. Since the Industrial Revolution, sources, doses, and types of nanoparticles have changed dramatically. In the last decade, the rapidly developing field of nanotechnology has led to an increase of engineered nanoparticles with novel physical and chemical properties. Regardless of whether this exposure is unintended or not, a careful assessment of possible adverse effects is needed. A large number of projects have been carried out to assess the consequences of combustion-derived or engineered nanoparticle exposure on human health. In recent years there has been a growing concern about the possible health influence of exposure to air pollutants during pregnancy, hence an implicit concern about potential risk for nanoparticle exposure in utero. Previous work has not addressed the question of whether nanoparticles may cross the placenta. Objective In this study we investigated whether particles can cross the placental barrier and affect the fetus. Methods We used the ex vivo human placental perfusion model to investigate whether nanoparticles can cross this barrier and whether this process is size dependent. Fluorescently labeled polystyrene beads with diameters of 50, 80, 240, and 500 nm were chosen as model particles. Results We showed that fluorescent polystyrene particles with diameter up to 240 nm were taken up by the placenta and were able to cross the placental barrier without affecting the viability of the placental explant. Conclusions The findings suggest that nanomaterials have the potential for transplacental transfer and underscore the need for further nanotoxicologic studies on this important organ system.

[1]  F. Ballester,et al.  Exposure to ambient air pollution and prenatal and early childhood health effects , 2004, European Journal of Epidemiology.

[2]  Abderrahim Nemmar,et al.  Cardiovascular and lung inflammatory effects induced by systemically administered diesel exhaust particles in rats. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[3]  A. Malek,et al.  The impact of cocaine and heroin on the placental transfer of methadone , 2009, Reproductive biology and endocrinology : RB&E.

[4]  Günter Oberdörster,et al.  Ultrafine particles in the urban air: to the respiratory tract--and beyond? , 2002, Environmental health perspectives.

[5]  Seishiro Hirano,et al.  A murine scavenger receptor MARCO recognizes polystyrene nanoparticles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Sandra L. Schmid,et al.  Regulated portals of entry into the cell , 2003, Nature.

[7]  P. Kaufmann,et al.  Pressure dependence of so‐called transtrophoblastic channels during fetal perfusion of human placental villi , 1997, Microscopy research and technique.

[8]  A. Jordan,et al.  Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  Wolfgang G Kreyling,et al.  Dosimetry and toxicology of ultrafine particles. , 2004, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[10]  J. Dancis,et al.  Transfer across the perfused human placenta of antipyrine, sodium and leucine. , 1972, American journal of obstetrics and gynecology.

[11]  H. Merkle,et al.  Transfer of Lipophilic Markers from PLGA and Polystyrene Nanoparticles to Caco-2 Monolayers Mimics Particle Uptake , 2002, Pharmaceutical Research.

[12]  Sharp Dg,et al.  Size and density of polystyrene particles measure by ultracentrifugation. , 1950 .

[13]  P. Couvreur,et al.  Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.

[14]  P. Gustin,et al.  Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model. , 2005, Toxicology.

[15]  R. Sager,et al.  Maternal—Fetal Transport of Immunoglobulin G and Its Subclasses During the Third Trimester of Human Pregnancy , 1994, American journal of reproductive immunology.

[16]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[17]  W. Hänggi,et al.  Production of Protein Hormones by Cultured Trophoblast Cells Isolated from Term and Early Placentae , 2000, American journal of reproductive immunology.

[18]  S. Schürch,et al.  Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. , 2006, Environmental science & technology.

[19]  Wolfgang Kreyling,et al.  Ultrafine Particles Cross Cellular Membranes by Nonphagocytic Mechanisms in Lungs and in Cultured Cells , 2005, Environmental health perspectives.

[20]  T. Blankenship,et al.  Comparative placental structure. , 1999, Advanced drug delivery reviews.

[21]  A. Nemmar,et al.  The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats , 2008, Experimental biology and medicine.

[22]  P. Myllynen,et al.  Kinetics of gold nanoparticles in the human placenta. , 2008, Reproductive toxicology.

[23]  J. Keelan,et al.  Drug Transfer and Metabolism by the Human Placenta , 2004, Clinical pharmacokinetics.

[24]  J. Challier Criteria for evaluating perfusion experiments and presentation of results. , 1985, Contributions to gynecology and obstetrics.

[25]  Minutes,et al.  MOLECULAR IMAGING IN DRUG DISCOVERY AND DEVELOPMENT , 2003 .

[26]  T. Nawrot,et al.  Particulate matter in the environment: pulmonary and cardiovascular effects , 2007, Current opinion in pulmonary medicine.

[27]  W. Hänggi,et al.  Capacity for hormone production of cultured trophoblast cells obtained from placentae at term and in early pregnancy. , 2001, Journal of assisted reproduction and genetics.

[28]  M. Panigel,et al.  [Radioangiographic study of circulation in the villi and intervillous space of isolated human placental cotyledon kept viable by perfusion]. , 1967, Journal de physiologie.

[29]  V. Ganapathy,et al.  Placental transporters relevant to drug distribution across the maternal-fetal interface. , 2000, The Journal of pharmacology and experimental therapeutics.

[30]  B. Shin,et al.  Ultrastructure of the Rodent Placental Labyrinth : A Site of Barrier and Transport , 1997 .

[31]  U. Frey,et al.  Air pollution during pregnancy and lung function in newborns: a birth cohort study , 2009, European Respiratory Journal.

[32]  J. Heyder,et al.  Instillation of Six Different Ultrafine Carbon Particles Indicates a Surface Area Threshold Dose for Acute Lung Inflammation in Mice , 2005, Environmental health perspectives.